EUVIMEDEUVIMED entdecken
Crossref

Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1)

Kerstin Rahn, Ali T Abdallah, Lin Gan, Shelley Herbrich, Roland Sonntag, Oscar Benitez, Prerna Malaney, Xiaorui Zhang, Ashely G Rodriguez, Jared Brottem, Gernot Marx, Tim H Brümmendorf und 5 weitere

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2024

DOI: 10.1016/j.bbagrm.2023.195004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2024. Verfasst von Kerstin Rahn und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, University Hospital RWTH Aachen University, Aachen, Germany; Department of Leukemia, The University of Texas M…. Hauptthemen laut MEDLINE: CCAAT-Enhancer-Binding Protein-alpha, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: NCI NIH HHS, RWTH Aachen, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deletions on the long arm of chromosome 9 (del(9q)) are recurrent abnormalities in about 2 % of acute myeloid leukemia cases, which usually involve HNRNPK and are frequently associated with other known aberrations. Based on an Hnrnpk haploinsufficient mouse model, a recent study demonstrated a function of hnRNP K in pathogenesis of myeloid malignancies via the regulation of cellular proliferation and myeloid differentiation programs. Here, we provide evidence that reduced hnRNP K expression results in the dysregulated expression of C/EBPα and additional transcription factors. CyTOF analysis revealed monocytic skewing with increased levels of mature myeloid cells. To explore the role of hnRNP K during normal and pathological myeloid differentiation in humans, we characterized hnRNP K-interacting RNAs in human AML cell lines. Notably, RNA-sequencing revealed several mRNAs encoding key transcription factors involved in the regulation of myeloid differentiation as targets of hnRNP K. We showed that specific sequence motifs confer the interaction of SPI1 and CEBPA 5' and 3'UTRs with hnRNP K. The siRNA mediated reduction of hnRNP K in human AML cells resulted in an increase of PU.1 and C/EBPα that is most pronounced for the p30 isoform. The combinatorial treatment with the inducer of myeloid differentiation valproic acid resulted in increased C/EBPα expression and myeloid differentiation. Together, our results indicate that hnRNP K post-transcriptionally regulates the expression of myeloid master transcription factors. These novel findings can inaugurate novel options for targeted treatment of AML del(9q) by modulation of hnRNP K function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CCAAT-Enhancer-Binding Protein-alphaLeukemia, Myeloid, AcuteAnimalsMiceHumansHeterogeneous-Nuclear Ribonucleoprotein KTranscription FactorsHeterogeneous-Nuclear RibonucleoproteinsCCAAT-Enhancer-Binding Proteins

Stichwörter der Autor:innen

AMLCEBPAHNRNPKSPI1del(9q)

Substanzen

CCAAT-Enhancer-Binding Protein-alphaHeterogeneous-Nuclear Ribonucleoprotein KTranscription FactorsHeterogeneous-Nuclear RibonucleoproteinsCEBPA protein, humanCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouse

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, University Hospital RWTH Aachen University, Aachen, Germany; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Interdisciplinary Center for Clinical Research (IZKF) Aachen, RWTH Aachen University, Germany; Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Ger…
  • Interdisciplinary Center for Clinical Research (IZKF) Aachen, RWTH Aachen University, Germany.
  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Internal Medicine III, University Hospital RWTH Aachen University, Aachen, Germany.
  • Department of Intensive Care Medicine, University Hospital RWTH Aachen University, Aachen, Germany.

Förderung

  • NCI NIH HHS
  • RWTH Aachen
  • National Cancer Institute
  • Leukemia and Lymphoma Society

Zitieren

APA

Rahn, K., Abdallah, A. T., Gan, L., Herbrich, S., Sonntag, R., Benitez, O., Malaney, P., Zhang, X., Rodriguez, A. G., Brottem, J., Marx, G., Brümmendorf, T. H., Ostareck, D. H., Ostareck-Lederer, A., Crysandt, M., Post, S. M., & Naarmann-de Vries, I. S. (2024). Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1). Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. https://doi.org/10.1016/j.bbagrm.2023.195004

Vancouver

Rahn K, Abdallah AT, Gan L, Herbrich S, Sonntag R, Benitez O, et al. Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1). Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2024. doi:10.1016/j.bbagrm.2023.195004

BibTeX
@article{Rahn2024,
  author = {Rahn, Kerstin and Abdallah, Ali T and Gan, Lin and Herbrich, Shelley and Sonntag, Roland and Benitez, Oscar and Malaney, Prerna and Zhang, Xiaorui and Rodriguez, Ashely G and Brottem, Jared and Marx, Gernot and Brümmendorf, Tim H and Ostareck, Dirk H and Ostareck-Lederer, Antje and Crysandt, Martina and Post, Sean M and Naarmann-de Vries, Isabel S},
  title = {Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1)},
  journal = {Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms},
  year = {2024},
  doi = {10.1016/j.bbagrm.2023.195004}
}
Kostenlos starten →